Craft
  • Home
  •  / Lantern Pharma
Lantern Pharma

Lantern Pharma

Market Capitalization

$56.4 M

2022-11-21

Lantern Pharma Summary

Company summary

Overview
Lantern Pharma is a biotechnology company developing precision cancer drugs. It offers therapies using genomic data, machine learning, and computational biology modeling to identify the patient groups most likely to respond to therapy and to clarify the potential underlying mechanism(s) of action.
Type
Public
Status
Active
Founded
2013
HQ
Dallas, TX, US | view all locations
Website
http://www.lanternpharma.com/
Cybersecurity rating
Sectors

Key people

  • Panna Sharma

    Panna Sharma, Chief Executive Officer, President and Director

  • David R. Margrave

    David R. Margrave, Chief Financial Officer and Secretary

  • Peter Nara
  • Kishor G. Bhatia

    Kishor G. Bhatia, Chief Scientific Officer

LocationsView all

1 location detected

  • Dallas, TX HQ

    United States

    1920 McKinney Ave 7th Floor

Lantern Pharma Financials

Summary financials

Net income (Q2, 2022)
($4.5M)
Cash (Q2, 2022)
$43.4M
EBIT (Q2, 2022)
($4.4M)
Enterprise value
$17.3M

Footer menu